2021; Jia et al. 2022), and mutations of this gene are also involved in the pathogenesis of other synucleinopathies (Nussbaum 2018; Orme et al. 2018; Tagliafierro and Chiba‐Falek 2016), as well as of neurodegenerative dementias (Scholz and Cobos 2024). Located on chromosome 4q22.1, SNCA comprises 12 exons, with complex regulatory regions in both intronic and exonic sequences, which impact its transcription levels (Clough et al. 2009). Here, SNCA is linked to synucleinopathy.